TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 26 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,271,000 | -34.2% | 2,842,477 | 0.0% | 0.02% | -41.4% |
| Q2 2019 | $1,933,000 | -50.4% | 2,842,477 | 0.0% | 0.03% | -67.4% |
| Q1 2019 | $3,894,000 | +117.4% | 2,842,477 | 0.0% | 0.09% | +78.0% |
| Q4 2018 | $1,791,000 | -69.3% | 2,842,477 | 0.0% | 0.05% | -71.8% |
| Q3 2018 | $5,827,000 | -24.1% | 2,842,477 | 0.0% | 0.18% | -25.0% |
| Q2 2018 | $7,675,000 | +30.4% | 2,842,477 | 0.0% | 0.24% | +68.6% |
| Q1 2018 | $5,884,000 | – | 2,842,477 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |